An open access journal
Cardiovascular Disease Research: New Insights into Prevention and Treatment
Abstract
Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality worldwide, prompting ongoing research efforts to advance prevention and treatment strategies. This paper provides an overview of recent insights into the pathophysiology, risk factors, and therapeutic modalities for CVD. Key topics include the role of lifestyle modifications, such as diet, exercise, and smoking cessation, in reducing CVD risk, as well as the efficacy of pharmacological interventions, including statins, antiplatelet agents, and antihypertensive drugs, in managing CVD-related conditions. Additionally, the paper explores emerging trends in cardiovascular research, such as the use of genetic testing, biomarkers, and novel imaging techniques for risk stratification and early detection of CVD. By synthesizing evidence from clinical trials and epidemiological studies, this paper aims to inform evidence-based approaches to CVD prevention, management, and public health policy.
Share and Cite
Article Metrics
References
- Mozaffarian, D., et al. (2015). Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation, 131(4), e29-e322.
- Yusuf, S., et al. (2004). Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The Lancet, 364(9438), 937-952.
- Benjamin, E. J., et al. (2019). Heart disease and stroke statistics—2019 update: a report from the American Heart Association. Circulation, 139(10), e56-e528.
- Ridker, P. M., et al. (2008). Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. New England Journal of Medicine, 359(21), 2195-2207.
- Roth, G. A., et al. (2017). Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. Journal of the American College of Cardiology, 70(1), 1-25.
- Yusuf, S., et al. (2016). Cardiovascular risk and events in 17 low-, middle-, and high-income countries. New England Journal of Medicine, 371(9), 818-827.
- Wang, T. J., et al. (2006). Plasma natriuretic peptide levels and the risk of cardiovascular events and death. New England Journal of Medicine, 355(4), 390-397.
- Arnett, D. K., et al. (2019). 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation, 140(11), e596-e646.